Biography

Steven Rodgers is a Partner of Morgan Stanley Capital Partners (MSCP). He is based in New York and has 22 years of investing experience. 

Mr. Rodgers joined Morgan Stanley in 2018 from J.H. Whitney Capital Partners, where he was a Senior Managing Director focusing on private equity investments. At Whitney Mr. Rodgers was a member of the Investment Committee and led the firm’s healthcare investing activities. Mr. Rodgers was a Managing Partner at the Riverside Company, a global private equity firm, where he led the firm’s efforts to invest in public companies utilizing a private equity approach. He was also a financial analyst at Alex. Brown & Sons Incorporated. 

Mr. Rodgers serves on the board of directors of Ovation Fertility, Aveanna Healthcare, 3B Scientific and Clarity Software and previously served on the board of directors of a number of other healthcare companies, including Amisys Synertech, Herbalife, Patient Keeper, and Symbion. Mr. Rodgers graduated, cum laude, from Dartmouth College, and holds an MBA from The Stanford University Graduate School of Business.
 
 
Steve is a member of the Morgan Stanley Capital Partners
 
 
 

May not represent all Team Members.

The information on this page is for informational purposes only. It is intended for the benefit of third party issuers and those seeking information about alternatives investment strategies. The information contained herein does not constitute and should not be construed as an offering of advisory services or an offer to sell or a solicitation of an offer to buy any securities in any jurisdiction in which such offer or solicitation, purchase or sale would be unlawful under the securities, insurance or other laws of such jurisdiction.

All investing involves risks, including a loss of principal. Alternative investments are speculative and involve a high degree of risk. These investments are designed for investors who understand and are willing to accept these risks. Performance may be volatile, and an investor could lose all or a substantial portion of his or her investment.

Please refer to the strategy detail page for important information on the strategy, including additional risk considerations.

 

Morgan Stanley Investment Management (Australia) Pty Limited operates under AFSL No: 314182.

Not to be shown, quoted or distributed to the public. The information shown in this website is not personal advice and does not take into account the investment objectives, financial situation or needs of any person.

Information on this website should not be considered a solicitation to buy, an offer to sell or a recommendation for any security in any jurisdiction where such an offer, solicitation or recommendation would be unlawful or unauthorized. In addition, investments may not be made via this website.

Past performance of any product described on this site is not a reliable indication of future performance.


Privacy & Cookies    •    Terms of Use

©  Morgan Stanley | Investment Management (Australia) Pty Limited ACN 122040037